Letter: psoriasiform eruption during vedolizumab therapy

Affiliations

¹ IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
² Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Dermatology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.
³ Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Pathology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.

Comment

Giuseppe Maria Garbo et al. Aliment Pharmacol Ther. 2019 Aug.

. 2019 Aug;50(3):342-343.

doi: 10.1111/apt.15389.

¹ IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
² Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Dermatology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.
³ Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Pathology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.

No abstract available

Comment on

Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Chaparro M, Garre A, Ricart E, Iborra M, Mesonero F, Vera I, Riestra S, García-Sánchez V, Luisa De Castro M, Martin-Cardona A, Aldeguer X, Mínguez M, de-Acosta MB, Rivero M, Muñoz F, Andreu M, Bargalló A, González-Muñoza C, Pérez Calle JL, García-Sepulcre MF, Bermejo F, Huguet JM, Cabriada JL, Gutiérrez A, Mañosa M, Villoria A, Carbajo AY, Lorente R, García-López S, Piqueras M, Hinojosa E, Arajol C, Sicilia B, Conesa AM, Sainz E, Almela P, Llaó J, Roncero O, Camo P, Taxonera C, Domselaar MV, Pajares R, Legido J, Madrigal R, Lucendo AJ, Alcaín G, Doménech E, Gisbert JP; GETECCU study group. Chaparro M, et al. Aliment Pharmacol Ther. 2018 Oct;48(8):839-851. doi: 10.1111/apt.14930. Aliment Pharmacol Ther. 2018. PMID: 30281832